Among All the Bugs

Metagenomic sequencing may soon be a tool to identify which bacterium is making a patient sick, says [email protected]. A recent study published in the Journal of the American Medical Association used such a culture-free approach to identify the Shiga toxin-producing Escherichia coli behind an outbreak in Germany in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.